GC/52/2 - IARC

Greenblatt MS, Brody LC, Foulkes WD, Genuardi
M, Hofstra RM, Olivier M, Plon SE, Sijmons RH, Sinilnikova
O, Spurdle AB (2008). Locus-specific databases
and recommendations to strengthen their
contribution to the classification of variants in cancer
susceptibility genes. Hum Mutat 29(11):1273-
1281.
Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi
F, Bouvard V, Benbrahim-Tallaa L, Guha N,
Galichet L, Cogliano V (2009). A review of human
carcinogens-Part A: pharmaceuticals. Lancet Oncol
10(1):13-14.
Guha N, Kwan ML, Quesenberry CP, Jr., Weltzien
EK, Castillo AL, Caan BJ (2009). Soy isoflavones
and risk of cancer recurrence in a cohort of breast
cancer survivors: the Life After Cancer Epidemiology
study. Breast Cancer Res Treat 118(2):395-405.
Guimaraes DP, Oliveira IM, de Moraes E, Paiva GR,
Souza DM, Barnas C, Olmedo DB, Pinto CE, Faria
PA, De Moura Gallo CV, Small IA, Ferreira CG, Hainaut
P (2009). Interferon-inducible guanylate binding
protein (GBP)-2: A novel p53-regulated tumor
marker in esophageal squamous cell carcinomas.
Int J Cancer 124(2):272-279.
Guyton KZ, Kyle AD, Aubrecht J, Cogliano VJ, Eastmond
DA, Jackson M, Keshava N, Sandy MS, Sonawane
B, Zhang L, Waters MD, Smith MT (2009).
Improving prediction of chemical carcinogenicity by
considering multiple mechanisms and applying toxicogenomic
approaches. Mutat Res Rev Mutat Res
681(2-3):230-240.
Hainaut P and Boyle P (2008). Curbing the liver cancer
epidemic in Africa. Lancet 371(9610):367-368.
Hainaut P and Wiman KG (2009). 30 years and a long
way into p53 research. Lancet Oncol 10(9):913-919.
Hakami R, Mohtadinia J, Etemadi A, Kamangar F,
Nemati M, Pourshams A, Islami F, Nasrollahzadeh
D, Saberi-Firoozi M, Birkett N, Boffetta P, Malekzadeh
R (2008). Dietary intake of benzo(a)pyrene
and risk of esophageal cancer in North of Iran. Nutr
Cancer 60(2):216-221.
Halkjaer J, Olsen A, Bjerregaard LJ, Deharveng G,
Tjonneland A, Welch AA, Crowe FL, Wirfalt E, Hellstrom
V, Niravong M, Touvier M, Linseisen J, Steffen
A, Ocke MC, Peeters PHM, Chirlaque MD, Larranaga
N, Ferrari P, Contiero P, Frasca G, Engeset
D, Lund E, Misirli G, Kosti M, Riboli E, Slimani N,
Bingham S (2009). Intake of total, animal and plant
proteins, and their food sources in 10 countries in
the European Prospective Investigation into Cancer
and Nutrition. Eur J Clin Nutr 63(Suppl. 4):S16-S36.
Hall J, Marcel V, Bolin C, Fernet M, Tartier L, Vaslin
L, Hainaut P (2009). The associations of sequence
variants in DNA-repair and cell-cycle genes with
cancer risk: genotype-phenotype correlations. Biochem
Soc Trans 37(Pt 3):527-533.
Hammet F, George J, Tesoriero AA, Jenkins MA,
Schroen C, Smith L, Grabosch-Meehan A, Dite G,
McCredie MR, Giles GG, Tavtigian SV, Hopper JL,
Southey MC (2008). Is BRCA2 c.9079 G > A a
predisposing variant for early onset breast cancer?
Breast Cancer Res Treat 109(1):177-179.
Hashibe M, McKay JD, Curado MP, Oliveira JC, Koifman
S, Koifman R, Zaridze D, Shangina O, Wunsch-
Filho V, Eluf-Neto J, Levi JE, Matos E, Lagiou P,
Lagiou A, Benhamou S, Bouchardy C, Szeszenia-
Dabrowska N, Menezes A, Dall’Agnol MM, Merletti F,
Richiardi L, Fernandez L, Lence J, Talamini R, Barzan
L, Mates D, Mates IN, Kjaerheim K, MacFarlane
GJ, Macfarlane TV, Simonato L, Canova C, Holcatova
I, Agudo A, Castellsague X, Lowry R, Janout V,
Kollarova H, Conway DI, McKinney PA, Znaor A, Fabianova
E, Bencko V, Lissowska J, Chabrier A, Hung
RJ, Gaborieau V, Boffetta P, Brennan P (2008).
Multiple ADH genes are associated with upper aerodigestive
cancers. Nat Genet 40(6):707-709.
Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague
X, Chen C, Curado MP, Dal Maso L, Daudt
AW, Fabianova E, Fernandez L, Wunsch-Filho V,
Franceschi S, Hayes RB, Herrero R, Kelsey K, Koifman
S, La Vecchia C, Lazarus P, Levi F, Lence JJ,
Mates D, Matos E, Menezes A, McClean MD, Muscat
J, Eluf-Neto J, Olshan AF, Purdue M, Rudnai P,
Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska
N, Talamini R, Wei Q, Winn DM, Shangina
O, Pilarska A, Zhang ZF, Ferro G, Berthiller J, Boffetta
P (2009). Interaction between tobacco and
alcohol use and the risk of head and neck cancer:
pooled analysis in the International Head and Neck
Cancer Epidemiology Consortium. Cancer Epidemiol
Biomarkers Prev 18(2):541-550.
Hatagima A, Costa EC, Marques CF, Koifman RJ,
Boffetta P, Koifman S (2008). Glutathione S-transferase
polymorphisms and oral cancer: A casecontrol
study in Rio de Janeiro, Brazil. Oral Oncol
44(2):200-207.
Heath SC, Gut IG, Brennan P, McKay JD, Bencko
V, Fabianova E, Foretova L, Georges M, Janout V,
Kabesch M, Krokan HE, Elvestad MB, Lissowska J,
Mates D, Rudnai P, Skorpen F, Schreiber S, Soria
JM, Syvanen AC, Meneton P, Hercberg S, Galan P,
Szeszenia-Dabrowska N, Zaridze D, Genin E, Cardon
LR, Lathrop M (2008). Investigation of the fine
structure of European populations with applications
to disease association studies. Eur J Hum Genet
16(12):1413-1429.
Heck JE, Chen Y, Grann VR, Slavkovich V, Parvez
F, Ahsan H (2008). Arsenic exposure and anemia
in Bangladesh: a population-based study. J Occup
Environ Med 50(1):80-87.
Heck JE, Sapkota A, Vendhan G, Roychowdhury
S, Dikshit RP, Jetly DH, Brennan P, Boffetta P,
Hashibe M (2008). Dietary risk factors for hypopharyngeal
cancer in India. Cancer Causes Control
19(10):1329-1337.
Heck JE, Ritz B, Hung RJ, Hashibe M, Boffetta P
(2009). The epidemiology of neuroblastoma: a review.
Paediatr Perinat Epidemiol 23(2):125-143.
Heck JE, Andrew AS, Onega T, Rigas JR, Jackson
BP, Karagas MR, Duell EJ (2009). Lung Cancer in a
US Population with Low to Moderate Arsenic Exposure.
Environ Health Perspect 117(11):1718-1723.
Helpap B and Egevad L (2008). Correlation of modified
Gleason grading with pT stage of prostatic
carcinoma after radical prostatectomy. Anal Quant
Cytol Histol 30(1):1-7.
Helpap B and Egevad L (2008). Correlation of modified
Gleason grading of prostate carcinoma with
age, serum prostate specific antigen and tumor extent
in needle biopsy specimens. Anal Quant Cytol
Histol 30(3):133-138.
Helpap B and Egevad L (2009). [Clinical insignificance
of prostate cancer : Are there morphological
findings?]. Urologe A 48(2):170-174.
Helpap B and Egevad L (2009). Modified gleason
grading. An updated review. Histol Histopathol
24(5):661-666.
Herceg Z and Paliwal A (2009). HBV protein as a
double-barrel shot-gun targets epigenetic landscape
in liver cancer. J Hepatol 50(2):252-255.
Hery C, Ferlay J, Boniol M, Autier P (2008). Changes
in breast cancer incidence and mortality in middleaged
and elderly women in 28 countries with Caucasian
majority populations. Ann Oncol 19(5):1009-
1018.
Hery C, Ferlay J, Boniol M, Autier P (2008). Quantification
of changes in breast cancer incidence and
mortality since 1990 in 35 countries with Caucasianmajority
populations. Ann Oncol 19(6):1187-1194.
Hofstra RM, Spurdle AB, Eccles D, Foulkes WD,
de Wind N, Hoogerbrugge N, Hogervorst FB, IARC
Unclassified Genetic Variants Working Group
(2008). Tumor characteristics as an analytic tool
for classifying genetic variants of uncertain clinical
significance. Hum Mutat 29(11):1292-1303.
Hosny G, Farahat N, Tayel H, Hainaut P (2008).
Ser-249 TP53 and CTNNB1 mutations in circulating
free DNA of Egyptian patients with hepatocellular
carcinoma versus chronic liver diseases. Cancer
Lett 264(2):201-208.
Hosny G, Farahat N, Hainaut P (2009). TP53 mutations
in circulating free DNA from Egyptian patients
with non-Hodgkin’s lymphoma. Cancer Lett
275(2):234-239.
Hours M, Bernard M, Arslan M, Montestrucq L, Richardson
L, Deltour I, Cardis E (2009). Can loud
noise cause acoustic neuroma? Analysis of the IN-
TERPHONE study in France. Occup Environ Med
66(7):480-486.
Huang J, Grotzer MA, Watanabe T, Hewer E, Pietsch
T, Rutkowski S, Ohgaki H (2008). Mutations in the
Nijmegen breakage syndrome gene in medulloblastomas.
Clin Cancer Res 14(13):4053-4058.
publications du personnel du circ 2008-2009
153